$1.83
-0.015-0.81%
Last update: Nov 6, 5:21 PM
Fate Therapeutics Inc
FATENASDAQ
Fate Therapeutics (FATE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.26 | $-0.26 | $-0.28 | $-0.27 |
| Actual | $-0.25 | $-0.25 | $-0.26 | $-0.27 |
| Surprise | +3.85% | +3.85% | +7.14% | 0.00% |
| Revenue | ||||
| Estimate | $1.3M | $1.2M | $1.6M | $1.3M |
| Actual | $0 | $2.1M | $1.3M | $1.4M |
| Surprise | -100.0% | +70.8% | -18.1% | +3.80% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.28 | $-0.27 | $-0.26 | $-0.27 |
| Revenue | ||||
| Consensus | $1.3M | $1.2M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.25 | $-0.26 | 3.85 % |
| Q2 | Aug 13, 2026 | $-0.25 | $-0.26 | 3.85 % |
| Q1 | May 13, 2026 | $-0.26 | $-0.28 | 7.14 % |
| Q4 | Feb 26, 2026 | $-0.27 | $-0.27 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0 | $1.26M | -100.0 % |
| Q2 | Aug 13, 2026 | $2.08M | $1.22M | 70.8 % |
| Q1 | May 13, 2026 | $1.30M | $1.59M | -18.1 % |
| Q4 | Feb 26, 2026 | $1.37M | $1.32M | 3.80 % |
